How to Choose Blood Collection Tubes for U.S. Clinics: A Complete Guide to Quality, Compliance, and Cost

Jun 20

Written By

Summary

Choose blood collection tubes based on the laboratory test, specimen requirements, additive, fill volume, handling instructions, and the analyzer or laboratory method—not simply on price.
U.S. clinics should verify FDA status, CLIA validation requirements, lot traceability, expiration dates, storage conditions, packaging integrity, and supplier reliability before purchasing.
Total cost includes collection devices, redraws, rejected specimens, staff time, waste disposal, inventory management, and compliance risks, so quality and Workflow compatibility should be evaluated alongside unit price.

Blood collection tubes are among the most frequently used consumables in outpatient clinics, physician offices, urgent care centers, hospitals, Mobile Phlebotomy services, and independent laboratories. They may appear to be simple plastic or glass containers, but the tube selected for a blood draw can affect specimen quality, laboratory accuracy, turnaround time, patient experience, regulatory compliance, and operating costs.

For U.S. clinics, purchasing decisions should therefore extend beyond comparing catalog prices. A tube must be appropriate for the intended test, compatible with the collection system and laboratory analyzer, available in the correct size and additive configuration, and supported by reliable documentation. A product that is inexpensive but causes hemolysis, insufficient specimen volume, clotting, contamination, or repeated redraws may be substantially more expensive over time.

The following factors provide a practical framework for evaluating blood collection tubes in the United States. Clinics should also coordinate purchasing decisions with their laboratory director, medical director, infection prevention staff, phlebotomy supervisor, quality department, and supply-chain team.

Match the Tube to the Intended Laboratory Test

The most important purchasing consideration is whether the tube is approved and validated for the tests the clinic performs. Different tests require different specimens, anticoagulants, preservatives, clot activators, separator gels, or trace-element controls. A tube designed for a serum Chemistry Test may be unsuitable for coagulation, hematology, blood bank, molecular, Toxicology, or Therapeutic Drug Monitoring applications.

Clinics should create a test-to-tube matrix that identifies the required tube for every commonly ordered test. This matrix should be based on the receiving laboratory’s specimen-collection manual, the laboratory’s standard operating procedures, manufacturer instructions, and applicable guidance from organizations such as the Clinical and Laboratory Standards Institute, the College of American Pathologists, and the Centers for Medicare & Medicaid Services.

Common tube categories include the following:

Serum tubes: These may contain no additive or a Clot Activator. They are commonly used for many chemistry, immunology, serology, and hormone tests.
Serum separator tubes: These contain a polymer gel and may also contain a Clot Activator. After centrifugation, the gel forms a barrier between serum and cellular components.
Plasma separator tubes: These are designed to produce plasma and may contain Heparin or another anticoagulant, depending on the intended testing.
EDTA tubes: Usually identified by lavender or purple caps, these are widely used for complete blood counts, many hematology tests, and some blood bank or molecular applications.
Citrate tubes: Usually identified by light-blue caps, these are used for coagulation testing. The blood-to-Anticoagulant ratio is critical, making correct fill volume especially important.
Fluoride or glycolysis-inhibitor tubes: These may be used for selected glucose or lactate testing, although laboratory requirements vary and some modern methods do not require the same additive.
Specialty tubes: These may be required for trace metals, lead, blood cultures, genomic testing, Therapeutic Drug Monitoring, cytogenetics, or other specialized procedures.

Color coding is useful, but it should never be the only identification method. Cap colors can vary by manufacturer and product line. The additive, specimen type, tube dimensions, fill requirement, and laboratory acceptance criteria should always be confirmed before purchase.

Understand Additives and Their Effects on Results

Tube additives are chemicals or materials that control clotting, preserve analytes, separate serum or plasma, or stabilize a specimen. They can also interfere with testing if the wrong tube is used, if the tube is underfilled, or if the specimen is transferred incorrectly.

Anticoagulants

Anticoagulants prevent clot formation by binding calcium or interfering with the coagulation pathway. EDTA, Sodium Citrate, and Heparin are among the most common examples, but they are not interchangeable.

EDTA is particularly useful for preserving cellular morphology, which is why it is commonly used for hematology testing. However, EDTA contamination can produce clinically significant errors. For example, carryover of EDTA into a serum or chemistry tube may falsely increase potassium and decrease calcium or magnesium. This is one reason that the order of draw is an important part of tube selection and phlebotomy training.

Sodium Citrate tubes used for coagulation tests require a precise ratio of blood to anticoagulant. A tube that is substantially underfilled contains too much citrate relative to the amount of blood. This can prolong clotting times and produce inaccurate results. Clinics should purchase citrate tubes in sizes that are appropriate for the patient population and the draw volume needed by the receiving laboratory.

Heparin tubes are frequently used for plasma chemistry testing. The specific type of Heparin, such as lithium or sodium Heparin, matters because the wrong salt can interfere with certain assays. Purchasing staff should confirm the exact additive rather than relying only on a general label such as “green-top tube.”

Clot Activators and Separator Gels

Clot activators can speed clot formation, while separator gels create a physical barrier after centrifugation. These products can improve Workflow, but they may not be suitable for every test or analyzer. Gel behavior can be affected by centrifugation speed, temperature, transport conditions, and specimen characteristics.

Some analytes may adsorb to tube components or be affected by the gel. Certain therapeutic drugs, hormones, vitamins, and specialized analytes may require a tube specifically validated by the testing laboratory. Clinics should not assume that all serum separator tubes are equivalent merely because they have similar colors or dimensions.

Evaluate Regulatory Status and Documentation

In the United States, blood collection tubes are medical devices and may be subject to oversight by the U.S. Food and Drug Administration. The regulatory pathway and requirements can differ depending on the tube’s intended use, design, additive, and claims. Clinics should request the manufacturer’s regulatory information and confirm that the product is legally marketed for the intended application.

Purchasing departments should maintain documentation that includes the product name, catalog number, manufacturer, intended use, additive, tube size, lot number, expiration date, and relevant regulatory information. Documentation should be readily available during internal audits, accreditation surveys, complaint investigations, and product recalls.

Regulatory clearance or authorization does not eliminate the clinic’s responsibility to validate or verify the product in its own testing environment. Under CLIA, laboratories must establish that a new device, method, or significant change performs as expected before reporting patient results. The exact validation or verification process depends on whether the clinic performs testing in-house, sends specimens to an outside laboratory, or operates as part of a larger health system.

Clinics should ask suppliers for current instructions for use, certificates of analysis when applicable, safety data, storage requirements, lot information, and change-notification policies. A supplier that cannot provide consistent product documentation may create unnecessary compliance and quality risks.

Confirm Compatibility with Laboratory Instruments and Methods

Tube compatibility is not limited to the physical ability to fit inside a centrifuge or analyzer rack. The tube must also work with the laboratory method, sample volume, barcode system, specimen transport process, and preanalytical equipment.

Automated analyzers may have specific requirements for tube diameter, height, base shape, cap design, barcode placement, and minimum specimen volume. A tube that works on one analyzer may not be suitable for another. Clinics using Pneumatic Tube Systems, automated sorters, aliquoters, or track systems should confirm compatibility before switching products.

Laboratory medicine literature consistently identifies the preanalytical phase as a major source of laboratory error. Published reviews often estimate that the preanalytical phase accounts for roughly 60% to 70% of laboratory errors, although the exact percentage varies by study design, setting, and definition of error. Tube selection, fill volume, mixing, centrifugation, transport, and storage are all part of this phase.

Before approving a new tube, the clinic or laboratory should consider a structured comparison that examines:

Whether the tube is accepted by every receiving laboratory for the intended tests.
Whether the specimen can be loaded directly onto existing analyzers or requires transfer.
Whether barcodes remain readable after refrigeration, transport, or centrifugation.
Whether the tube maintains an appropriate seal during transport.
Whether the tube’s recommended centrifugation conditions match current procedures.
Whether the tube produces an adequate specimen volume after separation.

Consider Tube Material, Design, and Safety Features

Most contemporary blood collection tubes are made from plastic, although glass tubes remain available for selected applications. Plastic tubes are generally lighter and less likely to shatter, which can reduce breakage risks during collection, transport, and disposal. Glass may still be preferred or required for certain tests or laboratory procedures, so the material decision should be test-specific.

Tube dimensions affect both patient experience and specimen capacity. Common sizes include small-volume pediatric or geriatric tubes, standard adult tubes, and specialty tubes with larger or smaller capacities. A clinic serving children, older adults, Oncology Patients, dialysis patients, or individuals with difficult venous access may benefit from a carefully selected range of low-volume tubes.

Smaller tubes can reduce the amount of blood collected, but they are not automatically appropriate for every test. The receiving laboratory must confirm minimum volume requirements, especially when multiple assays are ordered from one specimen. A short-draw tube can create a rejected specimen if the laboratory requires a larger dead volume or a specific blood-to-additive ratio.

Safety features also deserve attention. Clinics should evaluate tubes as part of the complete blood collection system, including needles, holders, transfer devices, and sharps containers. Safety-engineered devices are relevant to the Occupational Safety and Health Administration’s bloodborne pathogens requirements, which require employers to use engineering and work-practice controls to reduce occupational exposure to blood and other potentially infectious materials.

Purchasing teams should ask whether the tube’s cap is easy to identify, whether it remains secure during inversion and transport, and whether opening the tube creates unnecessary splash or aerosol risk. Product design should support standard precautions and the clinic’s exposure-control plan.

Assess Fill Volume, Draw Volume, and Patient Population

Tube capacity is not the same as the amount of blood required for a VALID test. The laboratory may specify a minimum fill volume, a preferred fill volume, or a ratio between blood and additive. These requirements are particularly important for coagulation tubes, pediatric tubes, and tests with limited specimen stability.

Clinics should assess their patient population before standardizing tube sizes. An adult primary-care office may routinely use standard-volume tubes, while a pediatric practice may require low-volume products. A cancer center or specialty clinic may need multiple tube sizes because patients may have anemia, small veins, central venous access devices, or frequent repeat testing.

Underfilling can cause inaccurate results, while overfilling may increase unnecessary blood loss. Excessive collection volume is a meaningful consideration for patients undergoing repeated laboratory testing. Although an individual tube may contain only a few milliliters, cumulative blood loss can become clinically relevant for hospitalized, pediatric, critically ill, or chronically tested patients.

Clinics should also examine dead volume. Dead volume is the amount of specimen that remains unavailable for testing because it is needed to cover the tube interior, Separator Gel, analyzer aspiration system, or transfer device. A tube that appears to have sufficient capacity may not yield enough usable specimen for all ordered assays.

Review Specimen Stability and Transport Requirements

Many U.S. clinics collect specimens that are transported to an off-site laboratory. In these settings, tube performance must be evaluated over the entire journey from collection through accessioning and testing.

Purchasers should confirm how long the specimen can remain stable in the selected tube, whether it must be refrigerated or protected from light, and whether it can be transported at room temperature. Temperature limits and stability periods differ by analyte and laboratory method. The tube alone cannot guarantee specimen stability, but its additive and separator design can influence the result.

Transport considerations include:

Resistance to leakage and cap displacement.
Ability to withstand vibration, pressure changes, and routine courier handling.
Compatibility with absorbent packaging and triple-packaging procedures when required.
Barcode durability and legibility.
Performance after refrigeration or exposure to approved temperature ranges.
Protection against light for light-sensitive analytes when applicable.

Specimen transport is also affected by federal and state requirements for packaging, labeling, and shipping of biological materials. Clinics should coordinate with the receiving laboratory and their courier to ensure that the selected tube and packaging system meet applicable requirements.

Prioritize Infection Prevention and Contamination Control

Blood collection tubes are single-use products and should be handled in a manner that prevents contamination. Packaging should protect tubes from moisture, dust, chemical exposure, and physical damage. Clinics should inspect cartons and individual tubes for cracked plastic, damaged caps, compromised seals, unusual discoloration, or missing labels.

Aseptic technique remains essential. Tubes should not be reused, opened unnecessarily, or stored in locations where they can be contaminated. Tube additives should not be transferred between containers. Staff should follow the manufacturer’s instructions and the clinic’s approved procedures for collection, mixing, labeling, transport, and disposal.

Clinics should also determine whether the tube design supports correct patient identification. The tube should have adequate space for required identifiers, barcode labels, collection time, collector identification, and other information required by the laboratory or health system. Misidentification is a high-risk event, and a tube that makes labeling difficult can contribute to preventable errors.

Compare Quality, Defect Rates, and Hemolysis Performance

Quality should be measured using actual performance data whenever possible. A supplier may describe a tube as premium or high quality, but purchasing decisions are stronger when supported by objective indicators such as Specimen Rejection rates, hemolysis rates, clotting frequency, leakage, cracked tubes, insufficient volume, and labeling problems.

Hemolysis is one of the most common reasons for Specimen Rejection in many clinical settings. It can result from needle size, collection technique, prolonged Tourniquet use, vigorous shaking, difficult draws, improper transport, or tube-related factors. Published studies have reported widely varying hemolysis rates, often from below 1% to several percent depending on the setting and methodology. Emergency departments and high-volume collection sites may experience higher rates than routine outpatient laboratories.

A small percentage can still create a substantial operational burden. For example, if a clinic collects 10,000 specimens per month and has a 2% rejection or recollection rate, approximately 200 patients may require additional attention. The true cost may include another appointment, staff communication, laboratory processing, courier coordination, patient dissatisfaction, and delayed diagnosis.

Before a large-scale conversion, clinics can conduct a limited evaluation using defined quality metrics. The evaluation should compare the current and proposed tubes under normal operating conditions. Results should be reviewed by the laboratory director or another qualified laboratory professional before the product is approved.

Examine Supplier Reliability and Supply Continuity

Availability is a critical consideration because blood collection tubes are high-use items. A clinic can experience significant disruption if a commonly used tube becomes unavailable, is placed on allocation, or arrives with a short expiration period.

During the Covid-19 pandemic, the United States experienced disruptions affecting many medical supplies, including specimen-collection products. Shortages demonstrated the importance of supplier diversification, realistic inventory levels, communication procedures, and approved alternatives. Clinics should not wait until an emergency to identify substitute tubes.

Supplier evaluation should include:

Historical fill rates and on-time delivery performance.
Manufacturing location and exposure to international transportation disruptions.
Availability of equivalent products from an alternate approved manufacturer.
Minimum order quantities and allocation policies.
Expiration dating at the time of delivery.
Recall notification and adverse-event communication procedures.
Ability to provide lot-level traceability.
Responsiveness of customer service and technical support.

Clinics should establish a documented shortage plan. The plan should identify which substitute tubes are acceptable, which tests require laboratory approval, how staff will be trained, and who has authority to approve a temporary product change.

Calculate Total Cost of Ownership

Unit price is important, but it is only one part of the financial analysis. A lower-cost tube may produce higher overall expenses if it causes more rejected specimens, requires manual aliquoting, does not work with automation, or has inconsistent availability.

Total cost of ownership may include:

Purchase price per tube.
Shipping, handling, and storage costs.
Special equipment or adapters.
Additional labor for processing or aliquoting.
Specimen Rejection and redraw costs.
Patient scheduling and communication costs.
Wasted reagents and laboratory testing capacity.
Expired inventory and disposal fees.
Training and implementation costs.
Potential compliance or quality-improvement expenses.

Clinics can estimate the financial effect of redraws by multiplying the number of rejected specimens by the average cost of staff time, patient contact, repeat collection, courier service, laboratory processing, and delayed care. Even a small reduction in rejection rates may justify a higher tube price if the product improves reliability.

Group purchasing organizations and health-system contracts may reduce prices, but contract terms should be reviewed carefully. A favorable price may be offset by restrictive minimum quantities, limited substitutions, short dating, or inflexible delivery schedules.

Plan Inventory and Storage Carefully

Blood collection tubes have expiration dates and storage requirements. Clinics should use a first-expiring, first-out system and avoid purchasing quantities that exceed realistic consumption. Overbuying can create expired inventory, especially when test volumes change or a clinic transitions to a new laboratory.

Storage areas should be clean, dry, secure, and maintained within the manufacturer’s specified temperature range. Tubes should be protected from excessive heat, freezing, direct sunlight, and physical compression. Cartons should not be stored in a way that damages caps or causes tubes to fall.

Inventory systems should track product by catalog number and lot number rather than by color alone. A barcode-based system can improve accuracy, but smaller clinics can also use standardized stock cards or electronic supply records. Par levels should reflect average daily use, seasonal fluctuations, supplier lead time, and emergency reserve needs.

Account for Environmental and Waste Considerations

Clinics generate regulated medical waste, including used blood collection tubes and associated materials. Purchasing decisions should consider the amount of packaging, the material composition, disposal requirements, and the possibility of reducing waste through appropriately sized tubes.

Smaller tubes may reduce blood volume and sometimes material use, but they must be clinically appropriate. Packaging made with less material is not automatically preferable if it compromises sterility, product protection, or transport integrity. Clinics should ask manufacturers about packaging reduction, recycled content where appropriate, and disposal guidance without compromising infection control.

Environmental considerations should be integrated into a broader procurement policy that also evaluates product performance, patient safety, regulatory requirements, and supply resilience. A product that frequently expires or causes redraws may generate more waste than a slightly more expensive product with better utilization.

Evaluate Staff Training and Workflow Impact

A tube conversion is a process change, not merely a purchasing change. Staff must understand the new tube’s additive, color, fill line, mixing instructions, order of draw, storage requirements, and test limitations. Training should include practical demonstrations and competency assessment when required by the clinic’s policies or applicable laboratory standards.

Visual similarity between tubes can cause confusion. Manufacturers may use similar cap colors for products with different additives, or the same color family may include multiple fill volumes. A clear, current collection guide should be available at every Phlebotomy Station.

Clinics should also review electronic health record and Laboratory Information System rules. If a test is linked to a specific specimen type, the system may need updates. Barcode labels, requisitions, courier manifests, and laboratory interfaces should be tested before implementation.

Change management should include a short transition period during which supervisors monitor errors and answer questions. Staff should know how to report tube defects, unexpected clotting, gel problems, hemolysis, or Discrepancies between the collection guide and the receiving laboratory’s instructions.

Use a Formal Product Evaluation Process

A formal evaluation reduces the likelihood of selecting a tube based solely on marketing claims or short-term price promotions. The evaluation team should include representatives from phlebotomy, laboratory operations, nursing, infection prevention, quality, purchasing, information technology, and finance when appropriate.

A useful evaluation process includes the following steps:

List all tests and specimen types used by the clinic.
Identify current rejection rates and the most common collection problems.
Define technical, regulatory, Workflow, and supply requirements.
Obtain product documentation and samples from qualified suppliers.
Confirm acceptance with each receiving laboratory.
Perform a limited comparison or validation when necessary.
Analyze quality results and total cost of ownership.
Approve the product through the clinic’s purchasing and quality process.
Update procedures, training materials, and electronic systems.
Monitor performance after implementation.

Post-implementation monitoring is essential. A new tube may perform well during a small trial but create problems at higher volume or across multiple locations. Clinics should review rejection rates, redraws, complaints, delivery performance, expiration waste, and product defects at regular intervals.

Questions to Ask Before Placing an Order

Before purchasing, U.S. clinics should ask the supplier and receiving laboratory several practical questions:

Is the tube legally marketed in the United States for the intended use?
What additive does it contain, and in what concentration or formulation?
Which tests and analyzers have been evaluated with the tube?
What is the recommended fill volume and minimum acceptable volume?
What are the required mixing, centrifugation, storage, and transport conditions?
What expiration period is normally provided at delivery?
How are lot numbers and recalls communicated?
Does the tube work with the clinic’s labels, barcodes, racks, centrifuges, and automation?
What is the supplier’s backup plan during shortages?
What technical support is available if the laboratory identifies a problem?

Conclusion

Selecting blood collection tubes is a clinical quality and operational decision as much as it is a purchasing decision. U.S. clinics should begin with the laboratory test and specimen requirement, then evaluate additives, fill volume, tube material, instrument compatibility, safety, transport stability, documentation, supplier reliability, and total cost.

Data from laboratory-quality studies consistently show that errors occurring before analysis can account for the majority of laboratory mistakes. Because tube choice is part of the preanalytical process, the right product can help reduce Specimen Rejection, redraws, delays, and avoidable patient inconvenience. Conversely, a poorly matched tube can compromise results even when the analyzer and assay are functioning correctly.

The best purchasing decision is not necessarily the tube with the lowest unit price. It is the product that reliably produces an acceptable specimen, fits the clinic’s Workflow, supports regulatory and laboratory requirements, remains available when needed, and delivers a favorable total cost over its entire use cycle. By combining technical evaluation with quality data and supply-chain planning, clinics can make blood collection safer, more consistent, and more cost-effective.

a-gloved-hand-holding-two-purple-top-tubes-with-blood-speciments

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.